As H. pylori infection becomes less prevalent following more widespread Hp eradication therapy, tests like GASTROClear, which can detect GC early regardless of H. pylori status, would become more important in the future, since individuals in whom H. pylori was eradicated may still have a reasonable risk of GC [27]. This evidence concerns the gene HP and gastric cancer.